Last Minute Lecture

Understanding Antianxiety and Antipsychotic Medications — Chapter 19 Summary from Clinical Psychopharmacology for Therapists Medications for anxiety and psychotic disorders play a vital role in managing complex mental health conditions. Chapter 19 of Clinical Psychopharmacology for Therapists focuses on the pharmacological strategies used to treat anxiety, schizophrenia, bipolar disorder, and related conditions. This chapter explores the mechanisms, uses, and risks of common antianxiety and antipsychotic drugs while unpacking the underlying neurochemical theories that inform their use—particularly the roles of GABA and dopamine . 🎥 Watch the video summary below to gain a clear and concise understanding of this chapter’s key points: Antianxiety Medications and the GABA System The chapter begins with an exploration of the primary classes of antianxiety medications : benzodiazepines, beta-blockers, antihistamines, and buspirone . Of these, benzodiazepines are most frequentl...

Breaking Down Anxiety Disorders — Chapter 9 Summary from Clinical Psychopharmacology for Therapists Anxiety is one of the most common and varied categories of mental health conditions. In Chapter 9 of Clinical Psychopharmacology for Therapists , we examine the diverse presentations of anxiety, their neurobiological underpinnings, and the tools available to clinicians for diagnosis and treatment. From generalized anxiety disorder (GAD) to panic disorder and phobias, this chapter explores how the brain processes fear—and how professionals can intervene with evidence-based care. Watch the full podcast-style summary above to learn how anxiety affects the brain and body, and how different treatment approaches can offer relief. Be sure to subscribe to Last Minute Lecture for more clinical breakdowns of key textbook chapters. The Spectrum of Anxiety Disorders Chapter 9 introduces ten major anxiety syndromes, including: Generalized Anxiety Disorder (GAD): Persistent, excessive...